Nakashima, M.; Goda, N.; Tenno, T.; Kotake, A.; Inotsume, Y.; Amaya, M.; Hiroaki, H.
Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape. Antioxidants 2023, 12, 952.
https://doi.org/10.3390/antiox12040952
AMA Style
Nakashima M, Goda N, Tenno T, Kotake A, Inotsume Y, Amaya M, Hiroaki H.
Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape. Antioxidants. 2023; 12(4):952.
https://doi.org/10.3390/antiox12040952
Chicago/Turabian Style
Nakashima, Mio, Natsuko Goda, Takeshi Tenno, Ayaka Kotake, Yuko Inotsume, Minako Amaya, and Hidekazu Hiroaki.
2023. "Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape" Antioxidants 12, no. 4: 952.
https://doi.org/10.3390/antiox12040952
APA Style
Nakashima, M., Goda, N., Tenno, T., Kotake, A., Inotsume, Y., Amaya, M., & Hiroaki, H.
(2023). Pharmacologic Comparison of High-Dose Hesperetin and Quercetin on MDCK II Cell Viability, Tight Junction Integrity, and Cell Shape. Antioxidants, 12(4), 952.
https://doi.org/10.3390/antiox12040952